These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36889133)

  • 21. A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
    Tsolis AC; Papandreou NC; Iconomidou VA; Hamodrakas SJ
    PLoS One; 2013; 8(1):e54175. PubMed ID: 23326595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous Human Proteins Interfering with Amyloid Formation.
    Gharibyan AL; Wasana Jayaweera S; Lehmann M; Anan I; Olofsson A
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid membranes induce structural conversion from amyloid oligomers to fibrils.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jun; 557():122-126. PubMed ID: 33862455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Horvath I; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration.
    Maïza A; Chantepie S; Vera C; Fifre A; Huynh MB; Stettler O; Ouidja MO; Papy-Garcia D
    FEBS Lett; 2018 Dec; 592(23):3806-3818. PubMed ID: 29729013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
    Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
    Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mechanistic survey of Alzheimer's disease.
    Tang Y; Zhang D; Gong X; Zheng J
    Biophys Chem; 2022 Feb; 281():106735. PubMed ID: 34894476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Model for the Surface-Catalyzed Protein Self-Assembly.
    Pan Y; Banerjee S; Zagorski K; Shlyakhtenko LS; Kolomeisky AB; Lyubchenko YL
    J Phys Chem B; 2020 Jan; 124(2):366-372. PubMed ID: 31867969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils.
    Sakalauskas A; Ziaunys M; Smirnovas V
    Sci Rep; 2020 Sep; 10(1):14466. PubMed ID: 32879381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies.
    Salahuddin P; Khan RH; Furkan M; Uversky VN; Islam Z; Fatima MT
    Int J Biol Macromol; 2021 Sep; 186():580-590. PubMed ID: 34271045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer's and Parkinson's Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery.
    Di Scala C; Armstrong N; Chahinian H; Chabrière E; Fantini J; Yahi N
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the effect of macromolecular crowding on aggregation behaviour of a model amyloidogenic Peptide.
    Gaharwar B; Gour S; Kaushik V; Gupta N; Kumar V; Hause G; Yadav JK
    Protein Pept Lett; 2015; 22(1):87-93. PubMed ID: 25267253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.
    Forloni G; Terreni L; Bertani I; Fogliarino S; Invernizzi R; Assini A; Ribizzi G; Negro A; Calabrese E; Volonté MA; Mariani C; Franceschi M; Tabaton M; Bertoli A
    Neurobiol Aging; 2002; 23(5):957-76. PubMed ID: 12392798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of Heterotypic Amyloids: α-Synuclein in Co-Aggregation.
    Bhasne K; Mukhopadhyay S
    Proteomics; 2018 Nov; 18(21-22):e1800059. PubMed ID: 30216674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Selectivity and Sensitivity of Oligomeric p-Phenylene Ethynylenes for Detecting Fibrillar and Prefibrillar Amyloid Protein Aggregates.
    Fanni AM; Monge FA; Lin CY; Thapa A; Bhaskar K; Whitten DG; Chi EY
    ACS Chem Neurosci; 2019 Mar; 10(3):1813-1825. PubMed ID: 30657326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
    Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid bilayers significantly modulate cross-fibrillation of two distinct amyloidogenic peptides.
    Gal N; Morag A; Kolusheva S; Winter R; Landau M; Jelinek R
    J Am Chem Soc; 2013 Sep; 135(36):13582-9. PubMed ID: 23952054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactive Phytocompounds: Anti-amyloidogenic Effects Against Hen Egg-White Lysozyme Aggregation.
    Chowdhury S; Kumar S
    Protein J; 2021 Feb; 40(1):78-86. PubMed ID: 33392981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion-Like Protein Aggregates and Type 2 Diabetes.
    Mukherjee A; Soto C
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid resolution molecular dynamics simulations of amyloid proteins interacting with membranes.
    Hashemi M; Lyubchenko YL
    Methods; 2022 Jan; 197():89-96. PubMed ID: 33727072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.